Advertisement

The Relationship of Diabetic Retinopathy to Preclinical Diabetic Glomerulopathy Lesions in Type 1 Diabetic Patients

The Renin-Angiotensin System Study

  1. Ronald Klein1,
  2. Bernard Zinman2,
  3. Robert Gardiner3,
  4. Samy Suissa4,
  5. Sandra M. Donnelly5,
  6. Alan R. Sinaiko6,
  7. Michael S. Kramer7,
  8. Paul Goodyer8,
  9. Scot E. Moss1,
  10. Trudy Strand6 and
  11. Michael Mauer6
  1. 1Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin
  2. 2Division of Medicine, University of Toronto, Toronto, Ontario, Canada
  3. 3Division of Medicine, McGill University, Montreal, Quebec, Canada
  4. 4Departments of Epidemiology and Biostatistics and Medicine, McGill University, Montreal, Quebec, Canada
  5. 5Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
  6. 6Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
  7. 7Departments of Pediatrics and Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
  8. 8Department of Pediatrics, McGill University, Montreal, Quebec, Canada
  1. Address correspondence to Ronald Klein, MD, MPH, Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, 610 North Walnut St., 460 WARF Madison, WI 53726. E-mail: kleinr{at}epi.ophth.wisc.edu

Abstract

Few epidemiological data exist regarding the correlation of anatomic measures of diabetic retinopathy and nephropathy, especially early in the disease processes. The aim of this study was to examine the association of severity of diabetic retinopathy with histological measures of diabetic nephropathy in normoalbuminuric patients with type 1 diabetes. The study included participants (n = 285) in the Renin-Angiotensin System Study (RASS; a multicenter diabetic nephropathy primary prevention trial) who were aged ≥16 years and had 2–20 years of type 1 diabetes with normal baseline renal function measures. Albumin excretion rate (AER), blood pressure, serum creatinine, and glomerular filtration rate (GFR) were measured using standardized protocols. Diabetic retinopathy was determined by masked grading of 30° color stereoscopic fundus photographs of seven standard fields using the Early Treatment Diabetic Retinopathy Study (ETDRS) severity scale. Baseline renal structural parameters, e.g., fraction of the glomerulus occupied by the mesangium or mesangial fractional volume [Vv(Mes/glom)] and glomerular basement membrane width, were assessed by masked electron microscopic morphometric analyses of research percutaneous renal biopsies. No retinopathy was present in 36%, mild nonproliferative diabetic retinopathy in 53%, moderate to severe nonproliferative diabetic retinopathy in 9%, and proliferative diabetic retinopathy in 2% of the cohort. Retinopathy was not related to AER, blood pressure, serum creatinine, or GFR. All renal anatomical end points were associated with increasing severity of diabetic retinopathy, while controlling for other risk factors. These data demonstrate a significant association between diabetic retinopathy and preclinical morphologic changes of diabetic nephropathy in type 1 diabetic patients.

Footnotes

  • R.K. has received honoraria for serving on the steering committee for the DIRECT Program from Astra-Zeneca. R.G. holds stock in and has received consulting fees from Merck. S.M.D. has received consulting fees from Merck.

    • Accepted October 19, 2004.
    • Received July 30, 2004.
| Table of Contents
Advertisement